EFTA01521007.pdf

GHISLAINE MAXWELL ACCT. For the Period 1/1/12 to 1/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 98.88 95.000 9,393.60 11,403.30 (2,009.70) 57.00 0.61 % 037411-10-5 APA 14.25 AT&T INC 0.00 00206R-10-2 T 440.00 BANK OF AMERICA CORP 7.13 944.000 6,730.72 10,148.85 (3,418.13) 37.76 0.56% 060505-10-4 BAC BB & T CORP 0.00 054937-10-7 BST 49.44 CITMIROUP INC NEW 30.72 358.000 10,997.76 14,048.52 (3,050.76) 14.32 0.13% 172967-42-4 C P COGNIZANT TECHNOLOGY SOLUTIONS CORP 71.75 0.00 CIA 192446-10-2 CTSH E I DU PONT DE NEMOURS & CO 50.89 224.000 11,399.38 11,537.62 (138.28) 367.36 3.22% 263534-104 DO E M C CORP MASS 25.76 468.000 12,055.68 12,378.64 (322.96) 268648-10-2 EMC ICROGER CO 23.76 265.000 6,296.40 6,587.16 (290.76) 121.90 1.94% 501044-10-1 KR JP Morgan Page 5 of 50 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048360 Chase CONFIDENTIAL SDNY_GM_00317558 EFTA01521007